70–80% of patients in LMICs are diagnosed at a late stage and typically die within two years of receiving their diagnosis
Runcie C.W. Chidebe shared a post on X:
“In this insightful comment on Nature Reviews Clinical Oncology, Carolyn Taylor shared: “I discovered that 70–80% of patients in LMICs are diagnosed at a late stage and typically die within 2 years of receiving their diagnosis”
Redefining priorities: a call for patient-centred cancer care and research
Author: Carolyn Taylor.
Source: Runcie C.W. Chidebe/X
Runcie C.W. Chidebe serves as the Executive Director of Project PINK BLUE and holds a position as an External Academic Board Member for the Birmingham and Lewisham African and Caribbean Health Inequalities Review. With a background in psychology, research, and social entrepreneurship, Runcie is deeply committed to cancer control advocacy and global health consultancy. He is dedicated to supporting underprivileged cancer patients, organizing free screenings for breast and cervical cancer in rural areas, fundraising for those in need, advocating for policy changes with governments, and providing specialized training for healthcare professionals in oncology and cancer awareness, including in local dialects.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023